| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -18,112 |
| Depreciation and amortization | 2,779 |
| Warranty provision | -14 |
| Inventory obsolescence | 451 |
| Share-based compensation | 1,663 |
| (gain) loss on change in fair value of warrants | -3,070 |
| Loss on change in fair value of term loans | 2,340 |
| Loss on issuance of first amendment term loan | -480 |
| Deferred income taxes | 0 |
| Loss on disposal of fixed asset | -1 |
| Addition of operating lease right of use asset | 67 |
| Amortization of operating lease right of use asset | 767 |
| Remeasurement of acquisition contingent consideration | 0 |
| Accretion of acquisition holdback liability | 0 |
| (amortization) accretion of investment of marketable securities | 41 |
| Accounts receivable, net | 4,303 |
| Contract assets | 5,967 |
| Inventories, net | 1,943 |
| Prepaid expenses and other | 5,937 |
| Accounts payable | 4,114 |
| Customer deposit | 18,062 |
| Accrued and other liabilities | 35 |
| Net cash used in operating activities | -8,762 |
| Purchases of marketable securities | 1,400 |
| Proceeds from maturities of marketable securities | 9,557 |
| Cash paid for acquisitions net of cash acquired | 0 |
| Cash paid for asset purchase holdback liability | 0 |
| Capital expenditures | 255 |
| Net cash provided by (used in) investing activities | 7,902 |
| Proceeds from issuance of close date term loan and warrants, net of issuance cost | 0 |
| Proceeds from issuance of first amendment term loan | 4,000 |
| Proceeds from offering of common stock, net of issuance costs | 0 |
| Proceeds from exercise of stock options | 49 |
| Payment of contingent consideration | 0 |
| Shares retained for payment of taxes in connection with settlement of restricted stock units | 18 |
| Shares retained for payment of taxes in connection with the exercise of stock options | 0 |
| Net cash provided by financing activities | 4,031 |
| Effect of foreign exchange rate on cash | 93 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 3,264 |
| Cash and cash equivalents at beginning of period | 5,290 |
| Cash and cash equivalents at end of period | 8,554 |
Genasys Inc. (GNSS)
Genasys Inc. (GNSS)